Literature DB >> 958035

Folate deficiency and neurological disorders in adults.

M I Botez.   

Abstract

The restless legs syndrome could represent a folate responsive disorder in both patients with acquired-folate deficiency and those with familial symptomatology. Patients with acquired folate-deficiency could be divided into two subgroups. (i) those with minor neurological signs (restless legs syndrome, vibration sense impairment and tactile hypoesthesia in both legs with diminished ankle jerks and a prolonged or assymetrical Achilles-reflex time) and (ii) those with major neurological signs (subacute combined degeneration with or without neuropathies). In some of these patients the classical triad of the malabsorption syndrome is replaced by another triad, constipation, abnormal jejunal biopsy and abnormal d-xylose absorption. A low folic serum acid level could induce minor neuropsychiatric symptoms while an additional low CSF folate could induce major neurological symptoms in spite of the presence of a normal erythrocyte folate level and in the absence of frank anemia. Possible further studies are described.

Entities:  

Mesh:

Year:  1976        PMID: 958035     DOI: 10.1016/0306-9877(76)90068-2

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  Effects of oral contraceptive usage on b(12) and folate levels.

Authors:  J A Mountifield
Journal:  Can Fam Physician       Date:  1985-08       Impact factor: 3.275

2.  Folate deficiency and neurological disease.

Authors:  M I Botez
Journal:  Br Med J       Date:  1976-09-18

3.  Supplementation with apple juice can compensate for folate deficiency in a mouse model deficient in methylene tetrahydrofolate reductase activity.

Authors:  A Chan; D Ortiz; E Rogers; T B Shea
Journal:  J Nutr Health Aging       Date:  2011-03       Impact factor: 4.075

4.  Differential Proteome Analysis of a Flor Yeast Strain under Biofilm Formation.

Authors:  Jaime Moreno-García; Juan Carlos Mauricio; Juan Moreno; Teresa García-Martínez
Journal:  Int J Mol Sci       Date:  2017-03-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.